CATHERINE KOHL: Open Payments
NPI 1801370812 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,483 in 104 payments from 14 companies in 2025. Trend: 2023 $2,697 · 2024 $2,067 · 2025 $2,483
Food & beverage: $2,483
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $647 |
| GlaxoSmithKline, LLC. | 12 | $307 |
| PFIZER INC. | 12 | $291 |
| Mallinckrodt Hospital Products Inc. | 8 | $253 |
| UCB, Inc. | 11 | $232 |
| Amgen Inc. | 10 | $209 |
| Radius Health, Inc. | 5 | $147 |
| E.R. Squibb & Sons, L.L.C. | 4 | $97 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Janssen Biotech, Inc. | 4 | $81 |
Products named: RINVOQ, BENLYSTA, ACTHAR, Bimzelx, XELJANZ, Tymlos, OCTAGAM IMMUNE GLOBULIN (HUMAN), ENBREL.
Industry payments across AL — which companies pay providers there.
